Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration.
Open Access
- 28 March 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (7) , 3070-3074
- https://doi.org/10.1073/pnas.92.7.3070
Abstract
Retinitis pigmentosa (RP) is a group of hereditary human diseases that cause retinal degeneration and lead to eventual blindness. More than 25% of all RP cases in humans appear to be caused by dominant mutations in the gene encoding the visual pigment rhodopsin. The mechanism by which the mutant rhodopsin proteins cause dominant retinal degeneration is still unclear. Interestingly, the great majority of these mutants appear to produce misfolded rhodopsin. We now report the isolation and characterization of 13 rhodopsin mutations that act dominantly to cause retinal degeneration in Drosophila; four of these correspond to identical substitutions in human autosomal dominant RP patients. We demonstrate that retinal degeneration results from interference in the maturation of wild-type rhodopsin by the mutant proteins.Keywords
This publication has 36 references indexed in Scilit:
- In the eye of the beholder: Visual pigments and inherited variation in human visionCell, 1994
- Arrestin Function in Inactivation of G Protein-Coupled Receptor Rhodopsin in VivoScience, 1993
- MOLECULAR GENETICS OF HUMAN VISUAL PIGMENTSAnnual Review of Genetics, 1992
- Constitutively active mutants of rhodopsinNeuron, 1992
- Phototransduction in itDrosophila: a paradigm for the genetic dissection of sensory transduction cascadesCurrent Opinion in Neurobiology, 1992
- Rhodopsin and autosomal dominant retinitis pigmentosaEye, 1992
- Investigation of Disease Mechanisms in Retinitis PigmentosaOphthalmic Paediatrics and Genetics, 1992
- Signal Transduction in the Visual System of DrosophilaAnnual Review of Cell Biology, 1991
- The cyclophilin homolog ninaA is required in the secretory pathwayCell, 1991
- Localization of binding sites for carboxyl terminal specific anti-rhodopsin monoclonal antibodies using synthetic peptidesBiochemistry, 1984